BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 9843011)

  • 21. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.
    Zouboulis CC; Bechara FG; Dickinson-Blok JL; Gulliver W; Horváth B; Hughes R; Kimball AB; Kirby B; Martorell A; Podda M; Prens EP; Ring HC; Tzellos T; van der Zee HH; van Straalen KR; Vossen ARJV; Jemec GBE
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):19-31. PubMed ID: 30176066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa.
    Aarts P; van Huijstee JC; van der Zee HH; van Straalen KR; Prens EP
    J Eur Acad Dermatol Venereol; 2024 May; 38(5):904-909. PubMed ID: 38112226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of antimicrobial resistance in lesions of hidradenitis suppurativa.
    Fischer AH; Haskin A; Okoye GA
    J Am Acad Dermatol; 2017 Feb; 76(2):309-313.e2. PubMed ID: 27742173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients.
    Delaunay J; Villani AP; Guillem P; Tristan A; Boibieux A; Jullien D
    Br J Dermatol; 2018 Jan; 178(1):e15-e16. PubMed ID: 28626900
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients.
    Bettoli V; Zauli S; Borghi A; Toni G; Minghetti S; Ricci M; Virgili A
    J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):125-6. PubMed ID: 23451831
    [No Abstract]   [Full Text] [Related]  

  • 26. An oral supplementation based on myo-inositol, folic acid and liposomal magnesium may act synergistically with antibiotic therapy and can improve metabolic profile in patients affected by Hidradenitis suppurativa: our experience.
    Donnarumma M; Marasca C; Palma M; Vastarella M; Annunziata MC; Fabbrocini G
    G Ital Dermatol Venereol; 2020 Dec; 155(6):749-753. PubMed ID: 30249083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic Treatment of Hidradenitis Suppurativa.
    Bettoli V; Join-Lambert O; Nassif A
    Dermatol Clin; 2016 Jan; 34(1):81-9. PubMed ID: 26617361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.
    Gener G; Canoui-Poitrine F; Revuz JE; Faye O; Poli F; Gabison G; Pouget F; Viallette C; Wolkenstein P; Bastuji-Garin S
    Dermatology; 2009; 219(2):148-54. PubMed ID: 19590173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical clindamycin versus oral tetracycline and placebo in acne vulgaris.
    Braathen LR
    Scand J Infect Dis Suppl; 1984; 43():71-5. PubMed ID: 6242073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.
    Alikhan A; Sayed C; Alavi A; Alhusayen R; Brassard A; Burkhart C; Crowell K; Eisen DB; Gottlieb AB; Hamzavi I; Hazen PG; Jaleel T; Kimball AB; Kirby J; Lowes MA; Micheletti R; Miller A; Naik HB; Orgill D; Poulin Y
    J Am Acad Dermatol; 2019 Jul; 81(1):91-101. PubMed ID: 30872149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why rifampin (rifampicin) is a key component in the antibiotic treatment of hidradenitis suppurativa: a review of rifampin's effects on bacteria, bacterial biofilms, and the human immune system.
    Scheinfeld N
    Dermatol Online J; 2016 Jun; 22(6):. PubMed ID: 27617596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acne inversa (hidradenitis suppurativa)].
    Iesalnieks I; Dornseifer U
    Chirurg; 2020 Apr; 91(4):293-300. PubMed ID: 31915870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective modified conservative tissue preserving protocol to treat stage I axillary hidradenitis suppurativa: a prospective cohort study of 627 patients with five years follow-up.
    Shirah BH; Shirah HA
    J Dermatolog Treat; 2017 Aug; 28(5):458-463. PubMed ID: 27981857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical clindamycin phosphate compared with oral tetracycline in the treatment of acne vulgaris.
    Katsambas A; Towarky AA; Stratigos J
    Br J Dermatol; 1987 Mar; 116(3):387-91. PubMed ID: 2952156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical treatment of hidradenitis suppurativa with clindamycin.
    Clemmensen OJ
    Int J Dermatol; 1983 Jun; 22(5):325-8. PubMed ID: 6347922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients.
    Riis PT; Saunte DM; Sigsgaard V; Villani AP; Guillem P; Pascual JC; Kappe NN; Vanlaerhoven AMJD; van der Zee HH; Prens EP; El-Domyati M; Abdel-Wahab H; Moftah N; Abdelghani R; Agut-Busquet E; Romaní J; Hlela C; van den Worm L; Bettoli V; Calamo G; Gürer MA; Beksaç B; Matusiak L; Glowaczewska A; Szepietowski JC; Emtestam L; Lapins J; Kottb HR; Fatani M; Weibel L; Theiler M; Delage-Toriel M; Lam TTH; Nassif A; Becherel PA; Dolenc-Voljc M; Doss N; Bouazzi D; Benhadou F; Del Marmol V; Jemec GBE
    Arch Dermatol Res; 2020 Dec; 312(10):715-724. PubMed ID: 32166376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks.
    Chang AL; Alora-Palli M; Lima XT; Chang TC; Cheng C; Chung CM; Amir O; Kimball AB
    J Drugs Dermatol; 2012 Mar; 11(3):333-9. PubMed ID: 22395584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa.
    van der Zee HH; Boer J; Prens EP; Jemec GB
    Dermatology; 2009; 219(2):143-7. PubMed ID: 19590174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical management and wound care approaches for hidradenitis suppurativa.
    Antia C; Alavi A; Alikhan A
    Semin Cutan Med Surg; 2017 Jun; 36(2):58-61. PubMed ID: 28538745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hidradenitis suppurativa (acne inversa): management of a recalcitrant disease.
    Lam J; Krakowski AC; Friedlander SF
    Pediatr Dermatol; 2007; 24(5):465-73. PubMed ID: 17958790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.